In humans and dogs, bullous pemphigoid (BP) is an autoimmune blistering disease associated with the production of basement membrane autoantibodies that target the 180-kd type XVII collagen (BP180, BPAG2) and/or the 230-kd plakin epidermal isoform BPAG1e (BP230). In two adult cats, an acquired dermatosis and stomatitis was diagnosed as BP subsequent to the fulfillment of the following criteria: 1) presence of cutaneous vesicles, erosions, and ulcers; 2) histologic demonstration of subepidermal vesiculation with inflammatory cells, including eosinophils; 3) in vivo deposition of IgG autoantibodies at the epidermal basement membrane zone; and 4) serum IgG autoantibodies targeting a 180-kd epidermal protein identified as type XVII collagen. In both cats, the antigenic epitopes targeted by IgG autoantibodies were shown to be situated in the NC16A ectodomain of type XVII collagen, a situation similar to that of humans and dogs with BP. Feline BP therefore can be considered a clinical, histopathologic, and immunologic homologue of BP in humans and dogs.
In humans, the binding of autoantibodies to glycoproteins located in the epidermal basement membrane zone often results in cutaneous blistering. 23 Based on immunochemical and molecular characterization of targeted autoantigens, the nosology of human vesicobullous diseases currently is being revised. The denomination of bullous pemphigoid (BP) presently is restricted to those blistering dermatoses characterized by inflammatory skin blisters, microscopical neutrophil-and eosinophil-rich subepidermal vesicles, and autoantibodies that target one or both BP antigens. These antigens consist of the following hemidesmosomal proteins: a 230-kd plakin epidermal isoform (BPAG1e, BP230) and/or the 180-kd transmembrane type XVII collagen (BPAG2, BP180). 3 BP is the most common autoimmune subepidermal bullous dermatosis of humans; it is the diagnosis achieved in ϳ70% of patients exhibiting antibasement membrane autoantibodies. 5 Since 1976, anecdotal cases of dogs with blistering and erosive diseases associated with basement membrane-specific autoantibodies have been reported under the umbrella diagnosis of BP. 2, 4, [9] [10] [11] 14, 15, 20, 28, [31] [32] [33] [35] [36] [37] In these cases, the specific antigen(s) targeted by auto-antibodies, however, was not determined. In 1995, the canine homologue of human BP was established with the demonstration of anti-BP180 autoimmunity in a dog with cutaneous vesicles. 17 The immunologic identity of canine and human BP was further strengthened with the recent demonstration that in both species circulating IgG autoantibodies target similar antigenic epitopes in the NC16A ectodomain of type XVII collagen (BP180). 7 However, during the last 20 years, feline cases of blistering dermatoses associated with antibasement membrane autoantibodies have not been reported.
The purpose of the present study was to demonstrate the existence of the feline counterpart of BP in humans and dogs. In two adult cats with vesicles, erosions, and ulcers, initial investigations led to the discovery of skin-fixed and circulating autoantibodies specific for basement membrane antigen(s). Immunoblotting confirmed that the circulating IgG autoantibodies were bound to a 180-kd epidermal protein comigrating with that targeted by a BP180-specific polyclonal antiserum. Furthermore, in the feline species, BP IgG autoantibodies also bind to peptides spanning the NC16A ectodomain of type XVII collagen. 
Material and Methods

Histopathology
Lesional skin biopsy specimens were obtained from two cats exhibiting clinical evidence of skin fragility. In cat No. 1, lesional skin biopsy specimens from the lips and palate were bisected upon arrival at the laboratory. One half was placed in neutral buffered formalin and processed for routine histopathologic examination. The second half was immersed in Optimal Cutting Temperature medium (OCT Tissue Tek, Baxter Diagnostics, McGaw Park, IL) and snap-frozen in isopentane cooled to its freezing point in liquid nitrogen. All frozen biopsies were kept at Ϫ70 C until further processed. Only formalin-fixed affected skin (lateral neck) and gingival samples were available from cat No. 2.
Immunofluorescence studies
Detection of tissue-bound autoantibodies. Skin-fixed IgG autoantibodies were detected by direct immunofluorescence (IF) testing of either frozen or paraffin-embedded skin sections using fluorescein-labeled anti-feline IgG antibodies (Cappel, Organon Technika, West Chester, PA) and a method described previously. 29 When formalin-fixed specimens were utilized, antigen retrieval was performed with 1% trypsin (Sigma, St. Louis, MO) proteolysis for 45 minutes at 37 C. Normal feline lip was used as a negative control, and skin from a dog affected with BP served as a positive control.
Detection of circulating autoantibodies. Initial screening of circulating autoantibodies was performed with an indirect IF method using normal feline lip and haired-skin substrates with serial dilutions of the cats' sera. The extinction titer of basement membrane-specific antibodies was determined using fluorescein-labeled anti-feline IgG antiserum as previously described. 29 Additional indirect IF studies were carried out using both canine and feline salt-split epithelial substrates. This method utilizes a normal skin specimen in which the epidermal basement membrane has been artificially cleaved within the lamina lucida. This technique has been validated for dogs. 16 Additionally, it has proven useful in differentiating BP from other canine autoimmune subepidermal blistering dermatoses. 29, 30 In all indirect IF studies, negative controls consisted of the pooled sera collected from five healthy cats. Serum from a dog with BP served as positive control. Additional studies were performed using a rabbit polyclonal antiserum generated by one of us (LSC) against a synthetic 18-mer peptide of the NC16A domain of human BP180 (sequence: RIRRS-ILPYGDSMDRIEK/peptide P2). This peptide contains the major antigenic epitopes recognized by sera of BP human patients. 13, 38 
Immunoblot analyses
Epidermis was removed from normal feline lip by incubation in 1 M NaCl, 20 mM ethylenediaminetetraacetic acid for 48 hours, snap-frozen in liquid nitrogen, ground to a fine powder, and incubated in extraction buffer containing 2% sodium dodecyl sulfate, 1 mM ethylene glycol-bis(␤-aminoethyl ether)N,N,NЈ,NЈ-tetraacetic acid, 60 mM Tris HCl, pH 6.8, 5% 2-mercaptoethanol, 1 mM dithiothreitol, and 1 mM 4-(2-aminoethyl)benzenesulfonyl fluoride. The extract was sonicated, boiled for 2 minutes, and centrifuged at 10,000 rpm for 10 minutes, and the supernatant was diluted with Lammeli sample buffer prior to electrophoresis using 5% acrylamide gels and sodium dioctyl sulfosuccinate. Immunoblotting was performed as previously described 26 using 1 : 50 dilutions of patients' or normal control feline sera, a 1 : 1,000 dilution of polyclonal antibody 594, which is directed against the NC16A domain of collagen XVII (donated by Dr. G. Giudice, Medical College of Wisconsin, Milwaukee, WI), 24 or a 1 : 1,000 dilution of nonimmune rabbit sera followed by appropriate anti-feline IgG or anti-rabbit IgG alkaline phosphatase (ALP)-conjugated secondary antibodies.
Enzyme-linked immunosorbent assay with recombinant NC16A peptides
To examine whether autoantibodies from cat Nos. 1 and 2 recognized the same antigenic epitopes that are targeted by the autoantibodies of humans with BP, enzyme-linked immunosorbent assays (ELISAs) were performed using synthetic peptides spanning the major human BP180 antigenic domain. 13, 38 Four nonoverlapping peptides encoding the human NC16A domain were synthesized (Tana Laboratories, Houston, TX), purified by high-performance liquid chromatography, and confirmed by mass spectrometry (Fig. 1) . Even though the sequence of feline BP180 currently is unknown, it is presumed to be homologous to that of its human counterpart because of the high homology existing between the NC16A domains of canine and human BP180. 7 Five micrograms of peptides P1-P4 were coated onto 96-well plates overnight at 4 C (Immulon flat-bottom microtiter plates, Dy- nex Technologies, Chantilly, VA). Dilutions (1 : 50) of the sera from cat Nos. 1 and 2, five normal cats, and one dog with BP were incubated with the peptides overnight at 4 C. Incubation with ALP-conjugated anti-IgG (AP161A and AP104A, Chemicon, Temecula, CA) was performed for 1 hour at room temperature. The reactions were visualized with ALP substrate (Bio-Rad, Hercules, CA) and counted on an ELISA reader as previously reported. 8
Results
Clinical summary
Cat No. 1, a 7-year-old castrated male domestic shorthair, was presented with a 1-month history of vesiculating, erosive, and crusting dermatitis. The lesions initially appeared at both lip commissures and spread bilaterally to involve the lips, concave aspect of the pinnae, and soft palate. Because pruritus was mild to moderate, excoriations to the chin and neck were selfinflicted. The lesions responded completely and rapidly to low immunosuppressive doses of prednisone (2 mg/kg, twice daily). After 30 days, the dosage of prednisone was reduced by half on a monthly basis, without further recurrence of skin lesions. Prednisone therapy was discontinued after 6 months. The cat has remained free of lesions, for the last 6 months without treatment.
Cat No. 2, a 3.5-year-old male Himalayan, had a 2year history of recurrent erosions, ulcerations, and crusts on the ear pinnae, lips, hard palate, and digits. Prednisone and doxycycline therapy only led to incomplete and temporal remission. The cat was euthanatized because of intractable constipation and rectal necrosis.
Histopathology
Hematoxylin and eosin (HE)-stained sections of lesions from cat No. 1 were similar. In all haired skin and mucosal samples, subepithelial vesiculation was the most prominent lesion (Fig. 2) . Occasionally, dermoepidermal clefting led to ulceration. Superficial dermal inflammation was either absent or mild ( Fig. 3 ) and consisted of dendritic/histiocytic cells and occasional neutrophil or eosinophil granulocytes.
Microscopic lesions from cat No. 2 were very similar to those of cat No. 1 (Fig. 4) . Subepidermal clefting also occurred along hair follicle infundibuli. Superficial dermal inflammation was more pronounced than in cat No. 1 and was composed of mast cells, lymphocytes, occasional eosinophils, and neutrophils.
Luna stain was applied to skin sections from both cats to assess the presence of eosinophils in the superficial dermis. 25 Occasional dermal eosinophils were seen in a superficial perivascular location in sections from both cats. In cat No. 1, rare eosinophils and free eosinophil granules also were seen at the dermoepidermal junction.
Immunofluorescence studies
Direct IF testing of all frozen skin biopsy specimens from cat No. 1 revealed a very strong deposition of IgG linearly and continuously distributed along the epidermal basement membrane (Fig. 5 ). The linear IgG deposit was also seen around the infundibuli and isthmus of hair follicles in samples of haired skin. Identical results were seen using sections of paraffinembedded skin from cat No. 2. In some sections from cat No. 1, low-intensity fluorescence was seen also between basal keratinocytes (Fig. 5 ). The linear basement membrane IgG deposition observed in the feline specimens was indistinguishable from that seen in skin sections of the dog with BP. IgG immunostaining of the normal feline skin biopsy was unremarkable.
Indirect IF testing using normal feline haired skin and lip substrates yielded similar results. Circulating IgG autoantibodies were bound to the epithelial basement membrane in a fine linear and continuous pattern (Fig. 6 ). The extinction titer was 1 : 5,000 for cat No. 1 and 1 : 100 for cat No. 2. When canine and feline salt-split substrates were used, the IgG autoantibodies labeled antigen(s) located on the epidermal side of the artificial clefts, a pattern suggestive of BP in humans and dogs (Fig. 7) . The indirect IF pattern observed using sera from both affected cats was identical to that seen with the canine BP serum and the polyclonal NC16A antibodies (data not shown). This similarity of pattern was indicative of close spatial proximity of targeted antigen(s). Indirect IF testing using the normal control feline pooled sera was negative at a 1 : 20 dilution.
Immunoblotting studies
Immunoblotting of sera from both affected cats was performed using adult feline lip epidermal extract. Serum samples from both cats specifically reacted with a protein of 180 kd apparent molecular mass (Fig. 8,  lanes 1, 2) . The band migrated to the same position as the one recognized by collagen XVII-NC16A polyclonal antiserum (Fig. 8, lane 3) . Normal control feline serum did not react with any epidermal protein (Fig.  8, lane 4) . Figure 9 illustrates the results of ELISAs showing that serum from the two affected cats contained IgG autoantibodies directed against epitopes situated in the NC16A ectodomain of type XVII collagen (BP180, BPAG2). Serum from cat No. 1 contained antibodies that bound P2 and P3 peptides. Serum from cat No. 2 demonstrated very high immunoreactivity against P2 and lower reactivity to P1, P3, and P4 oligopeptides. The positive control, consisting of the serum from one dog with BP, exhibited strong binding to P1 peptides. The five normal feline sera showed low reactivity against the tested peptides.
ELISAs
Discussion
The present study unequivocally establishes the existence of BP in cats. In the two affected cats, the diagnosis of BP was confirmed by fulfillment of the following criteria: 1) an acquired blistering, erosive, and ulcerative dermatosis affecting adult animals, 2) histologic demonstration of inflammatory subepidermal vesiculation with eosinophils, 3) in vivo deposition of IgG autoantibodies at the epidermal basement membrane zone, and 4) serum IgG autoantibodies targeting a 180-kd epidermal protein identified as type XVII collagen (BP180/BPAG2).
In humans, BP occurs most commonly in elderly individuals; most patients are women Ͼ60 years old. 3, 5 In contrast, BP in dogs and cats does not seem restricted to ageing individuals. In fact, one of the cats of the present study was affected initially around 1 year of age. This age of onset is similar to that of the dog with BP that was reported previously. 17 In humans, dogs, and cats, clinical lesions of BP consist of blistering lesions that evolve into erosions, ulcers, and crusts. 3, 17 Mucosal lesions of BP, seen typically in Ͻ40% of human patients, are usually transient and minor. 3 Lesions of feline BP, however, seem to have a higher predilection for lip commissures, oral mucosa, and hairless concave aspects of ear pinnae than for haired skin. The unique symptomatology of feline BP implies that it must be considered as a differential diagnosis for vesicular or erosive stomatitides.
The histopathologic features of human, canine, and feline BP appear remarkably similar. 3, 17 Dermoepidermal separation occurs without basal keratinocyte cytolysis. Subepidermal blisters contain a variable num-ber of inflammatory cells consisting of neutrophil and eosinophil granulocytes, lymphocytes, and histiocytic/ dendritic cells. 3, 17 In animals, the presence of eosinophils in vesicles seems to be a reliable marker for BP; these cells typically are not seen in autoimmune basement membrane diseases that target antigens other than BP180 (T. Olivry, unpublished data). 29 The finding of eosinophilic blisters in animal BP is in agreement with the recent demonstration that eosinophil activation may be involved in the generation of cutaneous lesions of BP in humans. 1, 6 In humans, dogs, and cats with BP, immunologic studies yield identical results. 3, 17 Direct IF testing reveals most commonly IgG and complement linearly distributed at the dermoepidermal junction. Because BP180 is membrane bound not only on basal aspects but also on lateral and apical sides of stratum basale keratinocytes, 18, 19 IF testing of animal and human specimens can reveal basal interkeratinocyte fluorescence in addition to basement membrane-specific immunostaining.
Indirect IF methods, using various epithelial substrates, have been very reliable in demonstrating the presence of circulating basement membrane-specific autoantibodies. In human patients with BP, the titer of circulating IgG autoantibodies detected with salt-split skin is usually higher than that determined with normal skin substrates. 22 The use of salt-split epithelial substrates most likely enhances binding of BP autoantibodies to the extracellular domain of BP180 because this method cleaves the basement membrane in the middle of the lamina lucida. 12 Furthermore, in both humans and dogs, salt-split skin indirect IF allows easy differentiation of BP from other dermatoses that target antigens located in the lower epidermal basement membrane. 12, 22, 29 Because many autoimmune subepidermal blistering diseases exhibit similar phenotypes, histologic lesions, and IF findings, final nosology cannot be achieved without identification of the specific antigens targeted by circulating autoantibodies. Immunoblotting using proteins isolated from various epithelial and dermal extracts permits initial determination of the molecular mass of targeted antigen(s). IgG autoantibodies from human patients with BP target usually a 230-kd and 180-kd protein doublet identified respectively as the plakin epidermal isoform BPAG1e and type XVII collagen BPAG2. 21, 34 To determine the specific identity of the autoantigen, selective immunoblotting, immunoprecipitation, or ELISA using purified proteins or recombinant peptides is mandatory. These studies, using immunoblotting of feline epidermal extracts and ELISA with NC16A synthetic peptides, have confirmed that canine and now feline BP IgG autoantibodies recognize antigenic epitopes in the NC16A ec-todomain of BP180 identical to those targeted by human BP sera. 7, 13, 27, 38 Because sera from human patients with BP often show reaction with BPAG1 as a 230-kd band on immunoblotting, it is of interest that neither of the feline sera significantly reacted to a 230-kd protein in epidermal extracts. Despite these observations, it is quite possible that other feline cases could demonstrate BPAG1 reactivity.
In summary, the present study clearly demonstrates the existence of an acquired blistering diseases of cats that appears identical to BP in humans and dogs. 3, 7, 17 In all three species, IgG autoantibodies target identical epitopes in the NC16A extracellular domain of type XVII collagen (BP180/BPAG2), confirming that canine and feline BP truly can be considered immunologic homologues for their human counterpart. Studies of passive transfer of human autoantibodies to the skin of dogs and cats might be useful for investigating the pathogenesis and novel therapeutic approaches for BP in humans.
